discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...
discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
Hyperbaric oxygen therapy has long been used to combat compression sickness in divers. But at a hospital in Israel they're using it to address a very different malady - post-traumatic stress disorder ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.
and non-motor symptom therapies in the treatment of Parkinson’s disease, according to new research. The current therapeutic landscape for Parkinson’s is heavily genericised, exhibiting a ...